Authors: SMEETS M RAYMAKERS R VIERWINDEN G LINSSEN P MUUS P DEWITTE T

Citation: M. Smeets et al., TREATMENT OF RESISTANT OR RELAPSED AML AND MDS WITH THE COMBINATION OF G-CSF, CYCLOSPORINE, IDARUBICIN AND CYTARABINE, British Journal of Haematology, 102(1), 1998, pp. 222-222

Authors: BOEZEMAN J RAYMAKERS R VIERWINDEN G LINSSEN P

Citation: J. Boezeman et al., AUTOMATIC-ANALYSIS OF GROWTH ONSET, GROWTH-RATE AND COLONY SIZE OF INDIVIDUAL BONE-MARROW PROGENITORS, Cytometry, 28(4), 1997, pp. 305-310

Authors: VANDERLELY N MINDERMAN H WESSELS H HILLEGERS M LINSSEN P PENNINGS A BRONS P BOEZEMAN J DEWITTE T

Citation: N. Vanderlely et al., DETECTION OF INCORPORATED IODODEOXYURIDINE IN COLONIES BY IMMUNOPEROXIDASE STAINING - A NOVEL METHOD TO MEASURE THE PROPORTION OF CYCLING COLONY-FORMING CELLS, Experimental hematology, 23(3), 1995, pp. 236-243

Authors: MINDERMAN H LINSSEN P VANDERLELY N WESSELS J BOEZEMAN J DEWITTE T HAANEN C

Citation: H. Minderman et al., TOXICITY OF IDARUBICIN AND DOXORUBICIN TOWARDS NORMAL AND LEUKEMIC HUMAN BONE-MARROW PROGENITORS IN RELATION TO THEIR PROLIFERATIVE STATE, Leukemia, 8(3), 1994, pp. 382-387

Authors: MINDERMAN H LINSSEN P WESSELS J HAANEN C

Citation: H. Minderman et al., CELL-CYCLE RELATED UPTAKE, RETENTION AND TOXICITY OF IDARUBICIN, DAUNORUBICIN AND DOXORUBICIN, Anticancer research, 13(4), 1993, pp. 1161-1165

Authors: MUUS P DONNELLY P SCHATTENBERG A LINSSEN P MINDERMAN H DOMPELING E DEWITTE T

Citation: P. Muus et al., IDARUBICIN-RELATED SIDE-EFFECTS IN RECIPIENTS OF T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTS ARE SCHEDULE-DEPENDENT, Seminars in oncology, 20(6), 1993, pp. 47-52